Olema Pharmaceuticals, Inc. (OLMA)
NASDAQ: OLMA · Real-Time Price · USD
8.12
-0.16 (-1.87%)
Nov 21, 2024, 1:29 PM EST - Market open
Olema Pharmaceuticals Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Nov '24 Nov 21, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Market Capitalization | 465 | 766 | 98 | 372 | 1,840 | - | |
| Market Cap Growth | 1.77% | 679.84% | -73.58% | -79.78% | - | - | |
| Enterprise Value | 261 | 492 | -122 | 66 | 1,861 | - | |
| Last Close Price | 8.28 | 14.03 | 2.45 | 9.36 | 48.08 | - | |
| PB Ratio | 2.38 | 3.02 | 0.50 | 1.31 | 5.44 | - | |
| P/TBV Ratio | 3.44 | 3.02 | 0.50 | 1.31 | 5.44 | - | |
| Debt / Equity Ratio | 0.01 | 0.01 | 0.01 | 0.01 | - | - | |
| Quick Ratio | 7.02 | 12.14 | 12.37 | 31.86 | 73.84 | 0.05 | |
| Current Ratio | 7.10 | 12.33 | 12.62 | 32.23 | 74.62 | 0.07 | |
| Return on Equity (ROE) | -51.76% | -42.82% | -43.47% | -22.83% | -13.13% | -473.25% | |
| Return on Assets (ROA) | -33.15% | -26.63% | -26.14% | -13.99% | -7.85% | -158.79% | |
| Return on Capital (ROIC) | -36.24% | -28.75% | -27.41% | -14.28% | -7.99% | -296.26% | |
| Earnings Yield | -27.52% | -12.61% | -106.63% | -19.11% | -1.20% | - | |
| FCF Yield | -21.69% | -10.93% | -83.88% | -14.05% | -1.08% | - | |
| Buyback Yield / Dilution | -29.11% | -13.13% | -1.19% | -462.91% | -170.75% | -2.80% | |
| Total Shareholder Return | -29.11% | -13.13% | -1.19% | -462.91% | -170.75% | -2.80% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.